Long-Term Assets: The sum of all assets classified as non-current.
Nasus Pharma Ltd. (NSRX) Long-Term Assets data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$4.86M |
|
-- |
|
|
Long-Term Assets |
-- |
$5.00M |
|
$2.16M |
|
-- |
|
-- |
|
$2.24M |
|
$2.77M |
|
$2.77M |
|
$2.77M |
|
-- |
|
| Cash Flow Statement Financials | |
$-4.92M |
|
$-3.01M |
|
$8.92M |
|
$0.31M |
|
$1.29M |
|
$0.98M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|